135 related articles for article (PubMed ID: 38471245)
21. Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic.
Mansouri A; Ghadakzadeh S; Maqbool T; Barnett C; Au K; Kongkham P; Bril V; Gelareh Z
Can J Neurol Sci; 2017 Sep; 44(5):577-588. PubMed ID: 27821212
[TBL] [Abstract][Full Text] [Related]
22. Increased epileptogenicity in a mouse model of neurofibromatosis type 1.
Sabetghadam A; Wu C; Liu J; Zhang L; Reid AY
Exp Neurol; 2020 Sep; 331():113373. PubMed ID: 32502580
[TBL] [Abstract][Full Text] [Related]
23. Correlation between NF1 genotype and imaging phenotype on whole-body MRI: NF1 radiogenomics.
Liu Y; Jordan JT; Bredella MA; Erdin S; Walker JA; Vangel M; Harris GJ; Plotkin SR; Cai W
Neurology; 2020 Jun; 94(24):e2521-e2531. PubMed ID: 32345730
[TBL] [Abstract][Full Text] [Related]
24. Epilepsy in neurofibromatosis type 1.
Pecoraro A; Arehart E; Gallentine W; Radtke R; Smith E; Pizoli C; Kansagra S; Abdelnour E; McLendon R; Mikati MA
Epilepsy Behav; 2017 Aug; 73():137-141. PubMed ID: 28633092
[TBL] [Abstract][Full Text] [Related]
25. Clinical and mutational spectrum of neurofibromatosis type 1-like syndrome.
Messiaen L; Yao S; Brems H; Callens T; Sathienkijkanchai A; Denayer E; Spencer E; Arn P; Babovic-Vuksanovic D; Bay C; Bobele G; Cohen BH; Escobar L; Eunpu D; Grebe T; Greenstein R; Hachen R; Irons M; Kronn D; Lemire E; Leppig K; Lim C; McDonald M; Narayanan V; Pearn A; Pedersen R; Powell B; Shapiro LR; Skidmore D; Tegay D; Thiese H; Zackai EH; Vijzelaar R; Taniguchi K; Ayada T; Okamoto F; Yoshimura A; Parret A; Korf B; Legius E
JAMA; 2009 Nov; 302(19):2111-8. PubMed ID: 19920235
[TBL] [Abstract][Full Text] [Related]
26. Breast cancer risk in neurofibromatosis type 1 is a function of the type of
Frayling IM; Mautner VF; van Minkelen R; Kallionpaa RA; Aktaş S; Baralle D; Ben-Shachar S; Callaway A; Cox H; Eccles DM; Ferkal S; LaDuca H; Lázaro C; Rogers MT; Stuenkel AJ; Summerour P; Varan A; Yap YS; Zehou O; Peltonen J; Evans DG; Wolkenstein P; Upadhyaya M
J Med Genet; 2019 Apr; 56(4):209-219. PubMed ID: 30530636
[TBL] [Abstract][Full Text] [Related]
27. Neurological complications involving the central nervous system in neurofibromatosis type 1.
Hsieh HY; Wu T; Wang CJ; Chin SC; Chen YR
Acta Neurol Taiwan; 2007 Jun; 16(2):68-73. PubMed ID: 17685129
[TBL] [Abstract][Full Text] [Related]
28. Clinical features and disease severity in patients with mosaic neurofibromatosis type 1: a single-center study and literature review.
Ejerskov C; Raundahl M; Gregersen PA; Handrup MM
Orphanet J Rare Dis; 2021 Apr; 16(1):180. PubMed ID: 33853649
[TBL] [Abstract][Full Text] [Related]
29. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of tibial osteopathy occurrence in neurofibromatosis type 1 Italian patients.
Morcaldi G; Clementi M; Lama G; Gabrielli O; Vannelli S; Virdis R; Vivarelli R; Boero S; Bonioli E
Am J Med Genet A; 2013 May; 161A(5):927-34. PubMed ID: 23463485
[TBL] [Abstract][Full Text] [Related]
31. Nevus anemicus in neurofibromatosis type 1: a potential new diagnostic criterion.
Marque M; Roubertie A; Jaussent A; Carneiro M; Meunier L; Guillot B; Pinson L; Pinson S; Bessis D
J Am Acad Dermatol; 2013 Nov; 69(5):768-775. PubMed ID: 23972508
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive neurological evaluation of a cohort of patients with neurofibromatosis type 1 from a single institution.
Angelova-Toshkina D; Decker JA; Traunwieser T; Holzapfel J; Bette S; Huber S; Schimmel M; Vollert K; Bison B; Kröncke T; Bramswig NC; Wieczorek D; Gnekow AK; Frühwald MC; Kuhlen M
Eur J Paediatr Neurol; 2023 Mar; 43():52-61. PubMed ID: 36905830
[TBL] [Abstract][Full Text] [Related]
33. Genotype-Phenotype Correlation in NF1: Evidence for a More Severe Phenotype Associated with Missense Mutations Affecting NF1 Codons 844-848.
Koczkowska M; Chen Y; Callens T; Gomes A; Sharp A; Johnson S; Hsiao MC; Chen Z; Balasubramanian M; Barnett CP; Becker TA; Ben-Shachar S; Bertola DR; Blakeley JO; Burkitt-Wright EMM; Callaway A; Crenshaw M; Cunha KS; Cunningham M; D'Agostino MD; Dahan K; De Luca A; Destrée A; Dhamija R; Eoli M; Evans DGR; Galvin-Parton P; George-Abraham JK; Gripp KW; Guevara-Campos J; Hanchard NA; Hernández-Chico C; Immken L; Janssens S; Jones KJ; Keena BA; Kochhar A; Liebelt J; Martir-Negron A; Mahoney MJ; Maystadt I; McDougall C; McEntagart M; Mendelsohn N; Miller DT; Mortier G; Morton J; Pappas J; Plotkin SR; Pond D; Rosenbaum K; Rubin K; Russell L; Rutledge LS; Saletti V; Schonberg R; Schreiber A; Seidel M; Siqveland E; Stockton DW; Trevisson E; Ullrich NJ; Upadhyaya M; van Minkelen R; Verhelst H; Wallace MR; Yap YS; Zackai E; Zonana J; Zurcher V; Claes K; Martin Y; Korf BR; Legius E; Messiaen LM
Am J Hum Genet; 2018 Jan; 102(1):69-87. PubMed ID: 29290338
[TBL] [Abstract][Full Text] [Related]
34. Prospective longitudinal overnight video-EEG evaluation in Phelan-McDermid Syndrome.
Khan OI; Zhou X; Leon J; Kessler R; Gaughan T; D'Souza P; Gropman A; Cohen N; Rennert O; Buckley A; Inati S; Thurm A
Epilepsy Behav; 2018 Mar; 80():312-320. PubMed ID: 29402632
[TBL] [Abstract][Full Text] [Related]
35. NF1 molecular characterization and neurofibromatosis type I genotype-phenotype correlation: the French experience.
Sabbagh A; Pasmant E; Imbard A; Luscan A; Soares M; Blanché H; Laurendeau I; Ferkal S; Vidaud M; Pinson S; Bellanné-Chantelot C; Vidaud D; Parfait B; Wolkenstein P
Hum Mutat; 2013 Nov; 34(11):1510-8. PubMed ID: 23913538
[TBL] [Abstract][Full Text] [Related]
36. Prevalence, Type, and Molecular Spectrum of
Pinna V; Daniele P; Calcagni G; Mariniello L; Criscione R; Giardina C; Lepri FR; Hozhabri H; Alberico A; Cavone S; Morella AT; Mandile R; Annunziata F; Di Giosaffatte N; D'Asdia MC; Versacci P; Capolino R; Strisciuglio P; Giustini S; Melis D; Digilio MC; Tartaglia M; Marino B; De Luca A
Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31487937
[TBL] [Abstract][Full Text] [Related]
37. [Neurofibromatosis type 1 (von Recklinghausen's disease or peripheral neurofibromatosis): from phenotype to gene].
Sabol Z; Kipke-Sabol L
Lijec Vjesn; 2005; 127(11-12):303-11. PubMed ID: 16583938
[TBL] [Abstract][Full Text] [Related]
38. C2 neurofibromas in neurofibromatosis type 1: genetic and imaging characteristics.
Waqar M; Huson S; Evans DG; Ealing J; Karabatsou K; George KJ; Soh C
J Neurosurg Spine; 2018 Oct; 30(1):126-132. PubMed ID: 30485203
[TBL] [Abstract][Full Text] [Related]
39. Phenotyping spinal abnormalities in patients with Neurofibromatosis type 1 using whole-body MRI.
Well L; Careddu A; Stark M; Farschtschi S; Bannas P; Adam G; Mautner VF; Salamon J
Sci Rep; 2021 Aug; 11(1):16889. PubMed ID: 34413392
[TBL] [Abstract][Full Text] [Related]
40. [Neurofibromatosis type 1 and associated clinical abnormalities in 27 children].
Syrbe S; Eberle K; Strenge S; Bernhard MK; Herbertz S; Bierbach U; Hirsch W; Froster UG; Kiess W; Merkenschlager A
Klin Padiatr; 2007; 219(6):326-32. PubMed ID: 18183640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
